Soltis Investment Advisors LLC Invests $566,000 in The Clorox Company (NYSE:CLX)

Soltis Investment Advisors LLC bought a new position in The Clorox Company (NYSE:CLX) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 3,486 shares of the company’s stock, valued at approximately $566,000.

A number of other large investors also recently modified their holdings of CLX. Wealth Group Ltd. bought a new stake in shares of Clorox in the 3rd quarter worth approximately $231,000. Livforsakringsbolaget Skandia Omsesidigt increased its stake in shares of Clorox by 256.4% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,112 shares of the company’s stock worth $181,000 after buying an additional 800 shares during the period. Valeo Financial Advisors LLC increased its position in Clorox by 8.0% during the 3rd quarter. Valeo Financial Advisors LLC now owns 3,710 shares of the company’s stock valued at $604,000 after purchasing an additional 276 shares during the period. Ritholtz Wealth Management purchased a new position in Clorox during the 3rd quarter valued at $214,000. Finally, Koshinski Asset Management Inc. increased its position in Clorox by 22.6% during the 3rd quarter. Koshinski Asset Management Inc. now owns 4,402 shares of the company’s stock valued at $717,000 after purchasing an additional 811 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

CLX has been the topic of a number of recent research reports. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and upped their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. DA Davidson lowered their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Evercore ISI upped their target price on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Finally, Barclays upped their target price on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, Clorox currently has a consensus rating of “Hold” and an average target price of $158.21.

Clorox Trading Down 0.9 %

Clorox stock opened at $147.08 on Tuesday. The stock has a market cap of $18.21 billion, a P/E ratio of 40.18, a PEG ratio of 2.52 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The firm’s 50 day moving average price is $161.06 and its 200-day moving average price is $159.07.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the firm earned $2.16 EPS. On average, equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.32%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio is presently 133.33%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.